{"id":3609976,"date":"2023-04-13T12:50:44","date_gmt":"2023-04-13T16:50:44","guid":{"rendered":"https:\/\/vip2-msd.com\/merckcom-migrated\/?post_type=story&p=3609976"},"modified":"2023-10-31T10:53:34","modified_gmt":"2023-10-31T14:53:34","slug":"exploring-one-medicine-for-one-patient","status":"publish","type":"story","link":"https:\/\/vip2-msd.com\/merckcom-migrated\/stories\/exploring-one-medicine-for-one-patient\/","title":{"rendered":"Individualized neoantigen therapies: exploring one medicine for one patient"},"content":{"rendered":"\n
\n
\n \n \n Innovation<\/small>\n <\/a>\n \n \n

\n Individualized neoantigen therapies: exploring one medicine for one patient\n <\/h1>\n

Scientists are researching new ways to help train the immune system to fight cancer <\/p>\n <\/div>\n\n

\n

April 13, 2023<\/p>\n

\n

Share this article<\/p>\n

\n \nFacebook icon<\/title><\/svg>\n<\/a><\/p>\n

\n\n\n\n\t.st0{fill:#00857C;}\n\n\nX icon<\/title><\/svg>\n<\/a><\/p>\n

\n \nLinkedin icon<\/title><\/svg>\n<\/a><\/p>\n

\n \nEmail icon<\/title><\/svg>\n<\/a><\/p>\n <\/div>\n <\/div>\n\n
\n
\n
\n \n \n \n \n \"Merck's\n <\/picture>\n\n <\/figure>\n \n
<\/div>